Dianthus Therapeutics Inc. (DNTH)
Market Closed
17 Jul, 20:00
$
105. 60
+10.25
+10.7499%
$
4.07B Market Cap
- P/E Ratio
- Div Yield
1.02M Volume
-6.17 Eps
$ 95.35
Previous Close 
Want to track DNTH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Dianthus Therapeutics Inc. (DNTH) Statistics
Valuation metrics
Market Cap 4.07B
Enterprise value 3.78B
Trailing P/E (ttm) -960
Forward P/E -15.57
PEG ratio -14,174.93
Price/Sales (ttm) 3,300
Price/Book (mrq) 4.22
Enterprise Value/Revenue 2,831.21
Enterprise Value/EBITDA -348.23
Overview
Shares outstanding 42.85M
Float 41.91M
Shares short 7.89M
% Held by insiders 0.03%
% Held by institutions 1.01%
Average volume (10 days) 1.71M
Average volume (90 days) 918.13K
Price summary
52-Week low 18.08
52-Week high 105.72
Beta 1.24
50-Day moving average 89.56
200-Day moving average 71.31
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:16
Last split Date 12 Sep 2023
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 30 Sep 2025
Profitability
Profit margin -8.48%
Operating margin -143.18%
Operational effectiveness
Return on assets -0.01%
Return on equity -0.02%
Income Statement
Revenue (ttm) 2.04M
Revenue per share (ttm) 0.03
Quarterly revenue growth (yoy) -0.79%
Gross profit (ttm) 2.04M
EBITDA -177.82M
Net income to common (ttm) -162.34M
Diluted EPS (ttm) -0.24
Quarterly earnings growth (yoy) -0.82%
Balance Sheet
Total cash (mrq) 404.3M
Total cash per share (mrq) 23.14
Total debt (mrq) 1.39M
Total Debt/Equity (mrq) 0
Current ratio (mrq) 29.25%
Book value per share (mrq) 25.01
Cash Flow
Cash flow statement -129.06M
Levered free cash flow (LFCF) -75.45M
